
The Centers for Disease Control and Prevention endorsed updated recommendations expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine over Johnson & Johnsonâs COVID-19 vaccine, as proposed by the agencyâs Advisory Committee on Immunization Practices.Â